For Dr. Renato Martins, the theme that Seattle Cancer Care Alliance chose for the American Society of Clinical Oncology's annual meeting -- "tomorrow's treatments today” -- is more than just a catchy slogan. It’s his life’s work, illustrated by a clinical trial that was instrumental in changing the way that lung cancer patients are treated.
Amy Dullard is an outlier. She was diagnosed with Stage III pancreatic cancer at 39; the average age is 71. Virtually none of the risk factors for pancreatic cancer apply to her, and she has no known genetic markers for this or any other cancer. Amy is a successful senior software engineer at Microsoft — historically, a role where men have been the majority. Her aim now is to continue setting a new bar — as a pancreatic cancer survivor.
The day after Bellevue firefighter Eric Rickert completed the challenging Scott Firefighter Stairclimb in 2015, he began feeling unusual abdominal pain. He hoped it was just a stomach flu, but the sharp, cramping aches lasted for days. After weeks of seemingly endless tests and doctor appointments, Eric received life-changing news: He had stage 4 mantle cell lymphoma (MCL).
SCCA's own Michael Mulligan, MD, explains some of the ways that he sees progress and hope for patients diagnosed with lung cancer in this short video. Some of the changes he discusses include video-assisted thoracic surgery, known as VATS. He also talks about being able to do surgery on a patient through an incision of one inch instead of what once required a 10-inch cut.